Register Cart 0

Generic placeholder image

Current Drug Therapy

Editor-in-Chief

ISSN (Print): 1574-8855
ISSN (Online): 2212-3903

Back Subscribe

EDITORIAL [Hot Topic: Anti-Vascular Endothelial Growth Factor (VEGF) Treatment of Ophthalmic Conditions (Guest Editor: Michael W. Stewart)]

Author(s): Michael W. Stewart

Volume 7, Issue 2, 2012

Page: [77 - 79] Pages: 3

DOI: 10.2174/157488512800675977

« Previous Next »

Rights & Permissions Print Cite

Article Metrics

17

Journal Information

For Authors

For Editors

For Reviewers

Explore Articles

Open Access

Open Access Articles

For Visitors

Related Articles

Aldose Reductase Inhibition: Emerging Drug Target for the Treatment of Cardiovascular Complications
Recent Patents on Cardiovascular Drug Discovery

New Insights in Congenital Diaphragmatic Hernia
Current Respiratory Medicine Reviews

An Update on Drug Interactions with the Herbal Medicine Ginkgo biloba
Current Drug Metabolism

Novel and Emerging Targeted Therapies of Colorectal Cancer
Current Clinical Pharmacology

Anti-VEGF Drugs in Eye Diseases: Local Therapy with Potential Systemic Effects
Current Pharmaceutical Design

Pharmacodynamics of Memantine: An Update
Current Neuropharmacology

Role of Vascular Progenitor Cells in Cardiovascular Disease
Current Pharmaceutical Design

Central Nervous System Vasculitis: Still More Questions than Answers
Current Neuropharmacology

Purinergic Signalling and Endothelium
Current Vascular Pharmacology

Vascular Endothelial Growth Factor (VEGF) Biochemistry and Development of Inhibitory Drugs
Current Drug Therapy

The Genetics of Small-Vessel Disease
Current Medicinal Chemistry

Monitoring Calcific Aortic Valve Disease: The Role of Biomarkers
Current Medicinal Chemistry

Cell-Penetrating Peptide Technology to Deliver Chaperones and Associated Factors in Diseases and Basic Research
Current Pharmaceutical Biotechnology

Safety and Efficacy of Dexamethasone Intravitreal Implant (Ozurdex) for the Treatment of Persistent Macular Edema Secondary to Retinal Vein Occlusion in Eyes Previously Treated with Anti-Vascular Endothelial Growth Factors
Current Drug Safety

Renal Injury Following Intravitreal Anti-VEGF Administration in Diabetic Patients with Proliferative Diabetic Retinopathy and Chronic Kidney Disease - A Possible Side Effect?
Current Drug Safety

Drug Delivery to the Back of the Eye Following Topical Administration: An Update on Research and Patenting Activity
Recent Patents on Drug Delivery & Formulation

VEGF Signal System: The Application of Antiangiogenesis
Current Medicinal Chemistry

Neuropilin Signalling in Vascular Development and Pathology
Current Angiogenesis (Discontinued)

Glucocorticoids: Structure, Signaling and Molecular Mechanisms in the Treatment of Diabetic Retinopathy and Diabetic Macular Edema
Current Molecular Medicine

Store-Dependent Ca2+ Entry in Endothelial Progenitor Cells As a Perspective Tool to Enhance Cell-Based Therapy and Adverse Tumour Vascularization
Current Medicinal Chemistry

© 2024 Bentham Science Publishers | Privacy Policy